Meeting

Meeting 1: Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease

When:

Monday, January 12, 2009 (8:30 AM)

Where:

Keck Center • 500 Fifth St. NW, Washington, DC 20001 Map

Topic(s):

Biomedical and Health Research, Diseases, Quality and Patient Safety

Activity:

Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease

Board(s):

Food and Nutrition Board, Board on Health Care Services, Board on Health Sciences Policy

The study committee convened to discuss the committee's charge from the Food and Drug Administration (FDA). Additionally, the Institute of Medicine invited the public to attend the two open sessions of this meeting that focused on the current methodologies used for biomarker qualification within the FDA and the various issues that the committee must consider when creating recommendations to the FDA. During these sessions, the Institute of Medicine welcomed individuals from the public to share relevant material with the committee.